| Title | Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways |
| Authors | Tong, Xiaoguang Barbour, Mark Hou, Kezuo Gao, Chao Cao, Shuang Zheng, Jingli Zhao, Yang Mu, Rong Jiang, Hui-Rong |
| Affiliation | China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang 110001, Peoples R China. Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland. China Med Univ, Affiliated Hosp 1, Dept Med Oncol, Shenyang 110001, Peoples R China. Peking Univ, Inst Rheumatol & Immunol, Peoples Hosp, Beijing 100044, Peoples R China. |
| Keywords | Fl-hIL-33 Ovarian cancer Metastasis Survival Invasion ALLERGIC AIRWAY INFLAMMATION INHIBITS TUMOR-GROWTH GENE-EXPRESSION BREAST-CANCER SOLUBLE ST2 CD8(+) T NK CELLS CARCINOMA IL-33 INVASIVENESS |
| Issue Date | 2016 |
| Publisher | MOLECULAR ONCOLOGY |
| Citation | MOLECULAR ONCOLOGY.2016,10,(1),113-125. |
| Abstract | Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer, it remains a huge challenge to understand the cellular and molecular mechanisms of the aggressive behavior of EOC cells. Here we investigated the role of an immunomodulatory cytokine IL-33 and its receptor ST2 in mediating the growth and metastasis of EOC. Our data show that both IL-33 and ST2 were highly up-regulated in EOC tumors compared with normal ovary and ovarian benign tumors, and the expression levels were further increased in tumor tissues at the metastatic site. The expression levels of IL-33 and ST2 were positively correlated with the Ki-67 expression, and negatively correlated with the patient survival time. Using EOC cell lines, we observed that cells knocked down of IL-33 gene by siRNA had reduced migratory and invasive potential, while full length human IL-33 (fl-hIL-33) promoted the invasive, migratory and proliferative capacity of EOC cells and this process could be inhibited by IL-33 decoy receptor sST2. Signaling pathway analysis suggested that IL-33 increased the phosphorylation of ERK and JNK which was blocked by sST2. Fl-hIL-33-induced increases in EOC cell migration, invasive potential and proliferation were specifically abrogated by treatment with the ERK inhibitor U0126 while JNK inhibitor SP600125 only disrupted IL-33-induced enhancement of cell viability. Taken together, our data suggest that IL-33/ST2 axis closely associates with poor prognosis of EOC patients, and it promotes ovarian cancer growth and metastasis through regulating ERK and JNK signaling pathways. Thus IL-33/ST2 might be potential prognosis markers and therapeutic targets for EOC patients. (C) 2015 Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies. |
| URI | http://hdl.handle.net/20.500.11897/417703 |
| ISSN | 1574-7891 |
| DOI | 10.1016/j.molonc.2015.06.004 |
| Indexed | SCI(E) PubMed |
| Appears in Collections: | 人民医院 |
